Covered recipient · General Payments record
MARCIA YVETTE PARRIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,798.68
- Reported across 276 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $729.14 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $220.58 | 11 |
| Novo Nordisk AS | $182.13 | 9 |
| ABBVIE INC. | $82.03 | 4 |
| Acerta Pharma LLC | $58.57 | 3 |
| PFIZER INC. | $47.26 | 2 |
| Phadia US Inc. | $34.76 | 2 |
| Exact Sciences Corporation | $30.78 | 1 |
| SANOFI-AVENTIS U.S. LLC | $27.45 | 1 |
| Seqirus USA Inc | $18.36 | 1 |
| Astellas Pharma US Inc | $13.67 | 1 |
| GlaxoSmithKline, LLC. | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.65 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105186600 | CMS |
| ABBVIE INC. | $17.94 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105186602 | CMS |
| ABBVIE INC. | $16.27 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105186604 | CMS |
| ABBVIE INC. | $23.17 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105186606 | CMS |
| Astellas Pharma US Inc | $13.67 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369179 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.93 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104737971 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105418221 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.64 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105677131 | CMS |
| Exact Sciences Corporation | $30.78 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114823675 | CMS |
| GlaxoSmithKline, LLC. | $13.55 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116618697 | CMS |
| Lilly USA, LLC | $17.82 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106329 | CMS |
| Lilly USA, LLC | $14.29 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148700 | CMS |
| Lilly USA, LLC | $20.04 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135157513 | CMS |
| Lilly USA, LLC | $22.46 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164339 | CMS |
| Lilly USA, LLC | $20.58 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106337 | CMS |
| Lilly USA, LLC | $21.67 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106333 | CMS |
| Lilly USA, LLC | $23.74 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106331 | CMS |
| Lilly USA, LLC | $18.28 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135150844 | CMS |
| Lilly USA, LLC | $21.13 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164337 | CMS |
| Lilly USA, LLC | $20.93 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106335 | CMS |
| Lilly USA, LLC | $19.64 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148702 | CMS |
| Novo Nordisk Inc | $17.86 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096752100 | CMS |
| Novo Nordisk Inc | $22.36 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930026 | CMS |
| Novo Nordisk Inc | $22.56 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096714953 | CMS |
| Novo Nordisk Inc | $22.75 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096662813 | CMS |
| Novo Nordisk Inc | $17.45 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096716446 | CMS |
| Novo Nordisk Inc | $20.38 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096628546 | CMS |
| Novo Nordisk Inc | $19.92 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097575137 | CMS |
| Novo Nordisk Inc | $16.43 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097661101 | CMS |
| Novo Nordisk Inc | $22.42 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096600709 | CMS |
| PFIZER INC. | $30.96 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131074964 | CMS |
| PFIZER INC. | $16.30 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131685238 | CMS |
| Phadia US Inc. | $18.48 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067582786 | CMS |
| Phadia US Inc. | $16.28 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067582788 | CMS |
| SANOFI-AVENTIS U.S. LLC | $27.45 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139661606 | CMS |
| Seqirus USA Inc | $18.36 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125629022 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.